Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.
暂无分享,去创建一个
[1] J. Crapo,et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[2] P. Mourani,et al. Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. , 2004, American journal of respiratory and critical care medicine.
[3] S. Abman,et al. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[4] T. Nagayasu,et al. Inhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung. , 2004, The Annals of thoracic surgery.
[5] B. Yoder,et al. Treatment of immature baboons for 28 days with early nasal continuous positive airway pressure. , 2004, American journal of respiratory and critical care medicine.
[6] C. Ackerley,et al. Defective Lung Vascular Development and Fatal Respiratory Distress in Endothelial NO Synthase–Deficient Mice: A Model of Alveolar Capillary Dysplasia? , 2004, Circulation research.
[7] D. Carlton,et al. Pulmonary vascular dysfunction in preterm lambs with chronic lung disease. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[8] A. Dykes,et al. Microtubule-dependent PKC-α localization in A7r5 smooth muscle cells , 2003 .
[9] C. Plopper,et al. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[10] B. Yoder,et al. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[11] G. Schmalzing,et al. Glu496Ala polymorphism of human P2X7 receptor does not affect its electrophysiological phenotype. , 2003, American journal of physiology. Cell physiology.
[12] Richard J Martin,et al. The role of endogenous and exogenous nitric oxide on airway function. , 2002, Seminars in perinatology.
[13] B. Yoder,et al. Developmental changes in nitric oxide synthase isoform expression and nitric oxide production in fetal baboon lung. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[14] N. Voelkel,et al. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[15] C. Tribble,et al. Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[16] R. Watkins,et al. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[17] S. Young,et al. Nitric oxide modulates branching morphogenesis in fetal rat lung explants. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[18] R. Watkins,et al. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.
[19] D. Carlton,et al. Reduced Endothelial Nitric Oxide Synthase in Lungs of Chronically Ventilated Preterm Lambs , 2000 .
[20] A. W. Murray,et al. NO protects alveolar type II cells from stretch-induced apoptosis. A novel role for macrophages in the lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[21] R. Bland,et al. Chronic Lung Disease in Early Infancy , 2000 .
[22] N. Voelkel,et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[23] T. L. Le Cras,et al. Early abnormalities of pulmonary vascular development in the Fawn-Hooded rat raised at Denver's altitude. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[24] D. Carlton,et al. Chronic Lung Injury in Preterm Lambs: Abnormalities of the Pulmonary Circulation and Lung Fluid Balance , 2000, Pediatric Research.
[25] J. Cooke,et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[26] M. Keszler,et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. , 2000, The New England journal of medicine.
[27] R. Lark,et al. LOW-DOSE NITRIC OXIDE THERAPY FOR PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN , 2000 .
[28] J. Coalson. 5. PATHOLOGY OF CHRONIC LUNG DISEASE OF EARLY INFANCY , 2000 .
[29] I. Yuhanna,et al. Nitric oxide (NO) upregulates NO synthase expression in fetal intrapulmonary artery endothelial cells. , 1999, American journal of respiratory cell and molecular biology.
[30] A. Knox,et al. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[31] R. Tuder,et al. Abnormal lung growth and the development of pulmonary hypertension in the Fawn-Hooded rat. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[32] J. Veinot,et al. Inhaled nitric oxide protects against hyperoxia-induced apoptosis in rat lungs. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[33] P. O’Farrell,et al. Nitric Oxide Contributes to Behavioral, Cellular, and Developmental Responses to Low Oxygen in Drosophila , 1999, Cell.
[34] D. Carlton,et al. Chronic lung injury in preterm lambs. Disordered respiratory tract development. , 1999, American journal of respiratory and critical care medicine.
[35] I. Yuhanna,et al. Nitric oxide synthase isoform expression in the developing lung epithelium. , 1999, The American journal of physiology.
[36] A. Husain,et al. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. , 1998, Human pathology.
[37] D. Carlton,et al. Continuous Inhalation of Nitric Oxide From Birth Preserves the Pulmonary Vasoconstrictor Response to Hypoxia in Chronically Ventilated Preterm Lambs• 1614 , 1998, Pediatric Research.
[38] D. Carlton,et al. Regulation of Endothelial Nitric Oxide Synthase Expression in Small Pulmonary Arteries and Airways of Chronically Ventilated Preterm Lambs. † 1700 , 1998, Pediatric Research.
[39] D. Carlton,et al. Continuous Inhalation of Nitric Oxide From Birth Decreases Airway Resistance and Bronchiolar Smooth Muscle in Chronically Ventilated Preterm Lambs • 1613 , 1998, Pediatric Research.
[40] R. D. Rudic,et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. , 1998, The Journal of clinical investigation.
[41] G. Garcı́a-Cardeña,et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.
[42] D. Carlton,et al. Role of neutrophils in lung vascular injury and edema after premature birth in lambs. , 1997, Journal of applied physiology.
[43] Richard J Martin,et al. Effect of Exogenous and Endogenous Nitric Oxide on the Airway and Tissue Components of Lung Resistance in the Newborn Piglet , 1997, Pediatric Research.
[44] R Bicknell,et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.
[45] W. Truog,et al. Airway muscle in preterm infants: changes during development. , 1997, The Journal of pediatrics.
[46] R. Pierce,et al. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. , 1997, The American journal of physiology.
[47] Jesse D. Roberts,et al. Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn , 1997 .
[48] Cook,et al. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. , 1997, The New England journal of medicine.
[49] A. Halbower,et al. Effects of Inhaled Nitric Oxide on Pulmonary Edema and Lung Neutrophil Accumulation in Severe Experimental Hyaline Membrane Disease , 1997, Pediatric Research.
[50] P. Dartevelle,et al. Prevention of ischemia-reperfusion lung injury by inhaled nitric oxide in neonatal piglets. , 1996, Journal of applied physiology.
[51] H. Granger,et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. , 1996, The American journal of physiology.
[52] T. Billiar,et al. The effect of nitric oxide on fetal pulmonary artery smooth muscle growth. , 1995, The Journal of surgical research.
[53] Jesse D. Roberts,et al. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. , 1995, Circulation research.
[54] S. Eddahibi,et al. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. , 1994, The Journal of clinical investigation.
[55] J. Ando,et al. Exogenous nitric oxide inhibits proliferation of cultured vascular endothelial cells. , 1994, Biochemical and biophysical research communications.
[56] S. Soifer,et al. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. , 1994, The Journal of clinical investigation.
[57] R. Klocke,et al. THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 1994 .
[58] D M Hyde,et al. Lung morphometry: a new generation of tools and experiments for organ, tissue, cell, and molecular biology. , 1993, The American journal of physiology.
[59] F. Morin,et al. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. , 1993, The Journal of pediatrics.
[60] J. Wain,et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. , 1993, Circulation research.
[61] J. Drazen,et al. Bronchodilator action of inhaled nitric oxide in guinea pigs. , 1992, The Journal of clinical investigation.
[62] E. Shaffer,et al. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.
[63] Jesse D. Roberts,et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn , 1992, The Lancet.
[64] J. Wain,et al. Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction , 1991, Circulation.
[65] J. Tomashefski,et al. Morphometric analysis of the lung in bronchopulmonary dysplasia. , 1991, The American review of respiratory disease.
[66] A. Cornelis,et al. Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia? A clinicopathologic study. , 1991, Biology of the neonate.
[67] S. Abman,et al. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. , 1990, The American journal of physiology.
[68] A. Hislop,et al. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease , 1990, Pediatric pulmonology.
[69] A. Hassid,et al. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.
[70] D. van Velzen,et al. Ventilator‐Related Pathology in the Extremely Immature Lung , 1989, Pathology.
[71] V. Bhutani,et al. Evaluation of neonatal pulmonary mechanics and energetics: A two factor least mean square analysis , 1988, Pediatric pulmonology.
[72] R. Guthrie,et al. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. , 1987, The American review of respiratory disease.
[73] E. Bancalari,et al. Serial determination of pulmonary function in infants with chronic lung disease. , 1987, The Journal of pediatrics.
[74] T. J. Breen,et al. Biostatistical Analysis (2nd ed.). , 1986 .
[75] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[76] R. Wolfe,et al. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. , 1985, Pediatrics.
[77] G. Vawter,et al. Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature. , 1984, Pediatric pathology.
[78] R. Burstein,et al. Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization. , 1982, Pediatrics.
[79] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[80] W. Northway,et al. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.
[81] J. Beazell,et al. Measurement of Pulmonary Edema , 1965, Circulation research.
[82] J. Emery,et al. The Number of Alveoli in the Terminal Respiratory Unit of Man During Late Intrauterine Life and Childhood , 1960, Archives of disease in childhood.